Danuglutide vs Semaglutide

Danuglutide is an experimental GLP-1 drug still in development, while semaglutide is an FDA-approved GLP-1 treatment sold under brand names like Ozempic, Wegovy, and Rybelsus. Semaglutide is approved for type 2 diabetes, obesity, chronic kidney disease, and reducing cardiovascular risk, whereas Danuglutide has no approved uses yet.

AI summary of the sources below.